# Duane Boise

Type: Person

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/duane-boise
Canonical HTML page: https://gethealthbrief.com/entity/duane-boise

## Timeline

- **2026-06-29**: Scheduled DEA hearing on rescheduling — A DEA administrative hearing is set to take place, which CEO Duane Boise calls less significant than the appellate court action.
- **2026-06-19**: MMJ announces advancement of legal challenge — Company issues press release declaring that the D.C. Circuit challenge has advanced and that the operative legal event is the court review, not the upcoming DEA hearing.
- **2026-06-18**: Statement of Issues filed — MMJIH files a Statement of Issues in the D.C. Circuit Court of Appeals seeking vacatur of the Final Order.
- **2026-04-22**: Acting Attorney General issues Final Order — Todd Blanche places marijuana into Schedule III of the Controlled Substances Act via a Final Order.
- **2024**: Initial DEA hearing process begins — A hearing process on marijuana rescheduling begins under the Controlled Substances Act, later terminated by the government according to petitioners.

## Recent coverage (3 stories)

### IRS 280E Relief and CMS Hemp Move Face Legal Uncertainty
2026-08-16 18:58:37 · Sentiment: Negative · Impact: 6/10 · Sources: 2

Health systems and health IT vendors building around CMS's hemp-derived cannabinoid initiative are on contested regulatory ground. A successful federal challenge could stay or remand the program, changing compliance and reimbursement calculations.
Full story: https://gethealthbrief.com/story/cms-hemp-280e-legal-uncertainty-health-systems

### DEA Rescheduling Hearing on June 29 Faces Pre-Emptive Legal Challenge—What It Means for Patients
2026-07-27 04:20:27 · Sentiment: Neutral · Impact: 6/10 · Sources: 2

MMJ International Holdings' appeal to the D.C. Circuit exposes a procedural flaw in the DEA's marijuana rescheduling that could delay patient access to new cannabinoid medicines and create confusion for healthcare providers trying to navigate the shifting regulatory landscape.
Full story: https://gethealthbrief.com/story/marijuana-rescheduling-legal-challenge-patient-access-cannabinoid-medicines

### Medical Cannabis Could See $2.2B Annual Tax Relief from Rescheduling, Challenger Claims
2026-07-12 01:16:54 · Sentiment: Positive · Impact: 9/10 · Sources: 1

MMJ International Holdings says moving cannabis to Schedule III would wipe out $2.24B in annual excess 280E taxes, unlocking capital for patient programs and medical research. The legal dispute spotlights the massive healthcare economic stakes of drug scheduling.
Full story: https://gethealthbrief.com/story/medical-cannabis-tax-relief-rescheduling

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.